Non-alcoholic fatty liver disease refers to fat deposition in the liver due to causes other than alcohol use. It is usually associated with obesity and metabolic syndrome. There are no approved drug treatments for non-alcoholic fatty liver disease (NAFLD).
However, lifestyle interventions such as diet, exercise, and the resulting weight loss have been shown to help improve the condition. Researchers have now found that even a short and moderate regime of daily exercise, regardless of volume or intensity, benefits obese and overweight adults with non-alcoholic fatty liver disease even in the absence of weight loss.
Non-Alcoholic Fatty Liver Disease Increases Risk of Atherosclerotic Lesions
An analysis reveals that the risk of early atherosclerotic lesions increases due to NAFLD regardless of established cardiovascular (CV) risk factors.
Advertisement
Researchers divided 48 participants were into four equal groups of 12 people- low-to-moderate intensity, high-volume aerobic exercise; high-intensity, low-volume aerobic exercise; low-to-moderate intensity, low-volume aerobic exercise; and placebo for an eight-week period. They assessed the change in liver fat by magnetic resonance spectroscopy (MRS).
All three groups, irrespective of the exercise regimen, showed improvement in liver fat of about 18-29% from the average baseline 7.5%, compared with the placebo group in which liver fat increased by an average of 14%. This improvement was independent of weight loss.
![Non-alcoholic Fatty Liver Disease On the Rise in US]( "Non-alcoholic Fatty Liver Disease On the Rise in US")
The US could soon be faced with an epidemic of Non-Alcoholic Fatty Liver Disease, one of the major contributing factors of chronic liver disease.
Nathan Johnson from the University of Sydney, Australia, and lead investigator of the study, said, "The results from our study show that all exercise doses, irrespective of volume or intensity, were efficacious in reducing liver fat and visceral fat by an amount that was clinically significant, in previously inactive, overweight, or obese adults compared with placebo. These changes were observed without clinically significant weight loss."
The study is published in the Journal of Hepatology.
Source: Medindia
Non-alcoholic Fatty Liver Disease On the Rise in US
The US could soon be faced with an epidemic of Non-Alcoholic Fatty Liver Disease, one of the major contributing factors of chronic liver disease.
Advertisement
Nathan Johnson from the University of Sydney, Australia, and lead investigator of the study, said, "The results from our study show that all exercise doses, irrespective of volume or intensity, were efficacious in reducing liver fat and visceral fat by an amount that was clinically significant, in previously inactive, overweight, or obese adults compared with placebo. These changes were observed without clinically significant weight loss."
The study is published in the Journal of Hepatology.
Source: Medindia
Avoid Junk Foods to Protect Liver from Non-Alcoholic Fatty Liver Disease
Even if you don't drink alcohol, you are at risk for non-alcoholic fatty liver disease, which is a common problem among overweight and obese people who eat junk food.
Advertisement
 Non-alcoholic Fatty Liver Disease Not Caused by FructoseFructose in an itself is not to blame for the increase in non-alcoholic fatty liver disease, a new analysis of human trials has found | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
Successful brain pacemaker implantation has helped a 51year old Parkinson's disease patient to revitalize her quality of life.
Recent recommendations on lifestyle behaviors to prevent progression of rheumatic and musculoskeletal diseases revealed.
The study offers insights into how psoriasis can trigger diabetes, heart disease, and inflammatory bowel disease.
Utilizing microparticles for therapy could mark a significant milestone in the fight against multiple sclerosis (MS) and other autoimmune diseases.
A study revealed that children with drug-resistant epilepsy (DRE) had the highest survival rate beyond 10 years when they underwent cranial epilepsy surgery.